The path forward for T cell engagers in patients with prostate cancer
AbstractT cell engagers (TCEs) recruit T cells to the tumor microenvironment (TME) to induce antitumor immune responses. TCEs have demonstrated promising clinical responses in patients with metastatic castration-resistant prostate cancer and have advanced into phase 3 clinical trials. Here we provid...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2026-02-01
|
| Collection: | Journal for ImmunoTherapy of Cancer |
| Accès en ligne: | https://jitc.bmj.com/content/14/2/e013905.full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|